Nicholas Saraceno, Senior Editor

Over the past year, Pharma Commerce’s digital coverage featured a variety of subject matters, ranging from how to calculate 340B prices, to the future of pharmacy.

The most popular pieces pertaining to the supply chain featured ADMs, vaccine supply chains, and wholesalers.

Items in this sector ranged touched on topics such as pharma shipping, container technology, and sustainability.

This year’s PC Podcast episodes ranged in topic, from DSCSA compliance to pharmacovigilance.

Camille Lee discusses the impact of commercial availability of Bimzelx for the treatment of moderate-to-severe plaque psoriasis in adults, along with the value of patient assistance/affordability programs.

A panel designs a conceptual framework in an effort to limit partiality.

The conference hosts a diversity, equity, and inclusion (DE&I) Summit featuring personal insights and experiences.

The seminar examines where members of the pharma supply chain stand in terms of preparation, being that the act has officially been enacted.

Session discusses ways to integrate digital pharmacies and hubs.

Panel uncovers ways to handle the increasing complexities and risks surrounding commercialization.

Conference keynote offers an industry outlook, including new commercialization challenges.

Study analyzes and predicts how conditions in research and development can be predicted via computer simulation.

Introducing a new style and feel to Pharma Commerce.

Back in Boston, Pharma Commerce tackles all things logistics at LogiPharma USA.

A study explores how supply and demand impact the value of medication.

Matt Wolf, president of biopharma services, Cencora, discusses the importance of partnership in helping to combat prescription drug abandonment and non-adherence.

Pharma Commerce editor takes a look back at 2023's impressionable editorial content.

Studies explore how both the UK and EU are handling these ongoing supply chain challenges.

Investigation notes a need for greater transparency in 340B program revenue and strengthened enforcement authority for the Health Resources and Services Administration.

The CDMO’s GMP plant will dedicate 2,500 square feet to the storage of finished products.

IQVIA report explores why these shortages are increasing, and how they can be mitigated.

Findings suggest that participants nationwide who were offered and accessed their online medical record has more than doubled in the past eight years, but racial and ethnic disparities continue.

Stem Cell Reports takes a look at DTC online advertising claims that these are ‘immune boosters.’

JMA Journal report describes how businesses in this Asian-Pacific nation are employing various strategies to reduce GHG emissions.

Session explains how to use this information to help bolster market intelligence, market access, and affordability strategies.

Conference presentation explores groundbreaking topics impacting the pharma industry.

Session explores how on-market products have done, and what to expect from new biosimilars.

Bill Roth provides insight as to how where chief commercial officers and access leaders can plan for a profitable product lifecycle.

Study describes how biotech startups can avoid competing with large pharma companies for financing.

Determination will affect future vaccine cost and accessibility, including in developing countries.